Langan SM, Irvine AD, Weidinger S (2020) Atopic dermatitis. Lancet 396(10247):345–360
Article CAS PubMed Google Scholar
Ständer S (2021) Atopic Dermatitis. N Engl J Med 384(12):1136–1143
Zeldin J, Ratley G, Shobnam N, Myles IA (2024) The clinical, mechanistic, and social impacts of air pollution on atopic dermatitis. J Allergy Clin Immunol 154(4):861–873
Article CAS PubMed Google Scholar
Paller AS, Kong HH, Seed P, Naik S, Scharschmidt TC, Gallo RL, Luger T, Irvine AD (2019) The microbiome in patients with atopic dermatitis. J Allergy Clin Immunol 143(1):26–35
Dainichi T, Kitoh A, Otsuka A, Nakajima S, Nomura T, Kaplan DH, Kabashima K (2018) The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis. Nat Immunol 19(12):1286–1298
Article CAS PubMed Google Scholar
Yue C, Zhou H, Wang X, Yu J, Hu Y, Zhou P, Zhao F, Zeng F, Li G, Li Y, Feng Y, Sun X, Huang S, He M, Wu W, Huang N, Li J (2024) Atopic dermatitis: pathogenesis and therapeutic intervention. MedComm 5(12):e70029
Article CAS PubMed PubMed Central Google Scholar
Nakajima S, Nakamizo S, Nomura T, Ishida Y, Sawada Y, Kabashima K (2024) Integrating multi-omics approaches in deciphering atopic dermatitis pathogenesis and future therapeutic directions. Allergy 79(9):2366–2379
Article CAS PubMed Google Scholar
Kim J, Kim BE, Berdyshev E, Bronova I, Bin L, Bae J, Kim S, Kim HY, Lee UH, Kim MS, Kim H, Lee J, Hall CF, Hui-Beckman J, Chang Y, Bronoff AS, Hwang D, Lee HY, Goleva E, Ahn K, Leung DYM (2023) Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction. Allergy 78(5):1292–1306
Article CAS PubMed Google Scholar
Leung DYM, Berdyshev E, Goleva E (2020) Cutaneous barrier dysfunction in allergic diseases. J Allergy Clin Immunol 145(6):1485–1497
Article CAS PubMed PubMed Central Google Scholar
Madison KC (2003) Barrier function of the skin: “la raison d’être” of the epidermis. J Invest Dermatol 121(2):231–241
Article CAS PubMed Google Scholar
Goleva E, Berdyshev E, Leung DY (2019) Epithelial barrier repair and prevention of allergy. J Clin Invest 129(4):1463–1474
Article PubMed PubMed Central Google Scholar
Schmuth M, Eckmann S, Moosbrugger-Martinz V, Ortner-Tobider D, Blunder S, Trafoier T, Gruber R, Elias PM (2024) Skin barrier in atopic dermatitis. J Invest Dermatol 144(5):989-1000.e1
Article CAS PubMed Google Scholar
Haftek M (2014) ‘Memory’ of the stratum corneum: exploration of the epidermis’ past. Br J Dermatol 171(Suppl):36–39
Elias PM, Hatano Y, Williams ML (2008) Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 121(6):1337–1343
Article CAS PubMed PubMed Central Google Scholar
Elias PM, Wakefield JS (2011) Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin Rev Allergy Immunol 41(3):282–295
Article CAS PubMed PubMed Central Google Scholar
Chamlin SL, Kao J, Frieden IJ, Sheu MY, Fowler AJ, Fluhr JW, Williams ML, Elias PM (2002) Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 47(2):198–208
Hülpüsch C, Rohayem R, Reiger M, Traidl-Hoffmann C (2024) Exploring the skin microbiome in atopic dermatitis pathogenesis and disease modification. J Allergy Clin Immunol 154(1):31–41
Berdyshev E (2024) Skin Lipid Barrier: Structure, Function and Metabolism. Allergy Asthma Immunol Res 16(5):445–461
Article PubMed PubMed Central Google Scholar
Kondo A, Takenaka Y, Fujiwara A, Takahashi S, Kitade-Miyayama M, Morifuji M, Kawashima M, Ishiguro N (2024) Changes in the composition of molecular species of covalently bound and free ceramides [EOS], and their correlation with disease severity in atopic dermatitis. Exp Dermatol 33(3):e15025
Article CAS PubMed Google Scholar
Nădăban A, Rousel J, El Yachioui D, Gooris GS, Beddoes CM, Dalgliesh RM, Malfois M, Rissmann R, Bouwstra JA (2023) Effect of sphingosine and phytosphingosine ceramide ratio on lipid arrangement and barrier function in skin lipid models. J Lipid Res 64(8):100400
Article PubMed PubMed Central Google Scholar
Blaess M, Csuk R, Schätzl T, Deigner HP (2024) Elongation of very long-chain fatty acids (ELOVL) in atopic dermatitis and the cutaneous adverse effect AGEP of drugs. Int J Mol Sci 25(17):9344
Shi VY, Leo M, Hassoun L, Chahal DS, Maibach HI, Sivamani RK (2015) Role of sebaceous glands in inflammatory dermatoses. J Am Acad Dermatol 73(5):856–863
Article CAS PubMed Google Scholar
Zouboulis CC, Coenye T, He L, Kabashima K, Kobayashi T, Niemann C, Nomura T, Oláh A, Picardo M, Quist SR, Sasano H, Schneider MR, Törőcsik D, Wong SY (2022) Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations. Front Immunol 13:1029818
Yin H, Qiu Z, Zhu R, Wang S, Gu C, Yao X, Li W (2023) Dysregulated lipidome of sebum in patients with atopic dermatitis. Allergy 78(6):1524–1537
Article CAS PubMed Google Scholar
Lin FJ, Huang YH, Tsao CH, Hsieh WC, Lo YH, Zouboulis CC, Chen HL, Liu FT (2023) Galectin-12 regulates immune responses in the skin through sebaceous glands. J Invest Dermatol 143(11):2120-2131.e7
Article CAS PubMed Google Scholar
Seiringer P, Hillig C, Schäbitz A, Jargosch M, Pilz AC, Eyerich S, Szegedi A, Sochorová M, Gruber F, Zouboulis CC, Biedermann T, Menden MP, Eyerich K, Törőcsik D (2024) Spatial transcriptomics reveals altered lipid metabolism and inflammation-related gene expression of sebaceous glands in psoriasis and atopic dermatitis. Front Immunol 15:1334844
Cavallo A, Camera E, Bottillo G, Maiellaro M, Truglio M, Marini F, Chavagnac-Bonneville M, Fauger A, Perrier E, Pigliacelli F, Picardo M, Cristaudo A, Mariano M (2024) Biosignatures of defective sebaceous gland activity in sebum-rich and sebum-poor skin areas in adult atopic dermatitis. Exp Dermatol 33(3):e15066
Article CAS PubMed Google Scholar
Kim EN, Lee HS, Jeong GS (2022) Callicarpa dichotoma leaf extract alleviates atopic dermatitis through the suppression of T cells and keratinocytes activation. Pharmaceuticals (Basel) 15(10):1280
Dubin C, Del Duca E, Guttman-Yassky E (2021) The IL-4, IL-13 and IL-31 pathways in atopic dermatitis. Expert Rev Clin Immunol 17(8):835–852
Article CAS PubMed Google Scholar
Berdyshev E, Goleva E, Bissonnette R, Bronova I, Bronoff AS, Richers BN, Garcia S, Ramirez-Gama M, Taylor P, Praestgaard A, Agueusop I, Jurvilliers P, Boguniewicz M, Levit NA, Rossi AB, Zhang A, Leung DYM (2022) Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis. Allergy 77(11):3388–3397
Article CAS PubMed Google Scholar
Simpson EL, Paller AS, Siegfried EC, Boguniewicz M, Sher L, Gooderham MJ, Beck LA, Guttman-Yassky E, Pariser D, Blauvelt A, Weisman J, Lockshin B, Hultsch T, Zhang Q, Kamal MA, Davis JD, Akinlade B, Staudinger H, Hamilton JD, Graham NMH, Pirozzi G, Gadkari A, Eckert L, Stahl N, Yancopoulos GD, Ruddy M, Bansal A (2020) Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial. JAMA Dermatol 156(1):44–56
Le Floc’h A, Allinne J, Nagashima K, Scott G, Birchard D, Asrat S, Bai Y, Lim WK, Martin J, Huang T, Potocky TB, Kim JH, Rafique A, Papadopoulos NJ, Stahl N, Yancopoulos GD, Murphy AJ, Sleeman MA, Orengo JM (2020) Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation. Allergy 75(5):1188–1204
Gittler JK, Shemer A, Suárez-Fariñas M, Fuentes-Duculan J, Gulewicz KJ, Wang CQ, Mitsui H, Cardinale I, de Guzman Strong C, Krueger JG, Guttman-Yassky E (2012) Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 130(6):1344–1354
Comments (0)